Table 5

The incidence case number of multiple myeloma and trend in crude incidence rates and age-standardized incidence rates per million population in the Republic of Korea from 1999 to 2018.

Years	N of cases				CIR	ASR^a)	ASR^a)
Years	Men	Women	Total	AAPC (%)	CIR	ASR^a)	AAPC (%)	IRR (per yr)
1999	257	212	469	7.33^b)	9.94415	10.22460	3.05^b)	1.030^b)
2000	275	217	492		10.35046	10.35046
2001	313	251	564		11.78017	11.46171
2002	328	239	567		11.78164	11.07893
2003	331	285	616		12.75141	11.55148
2004	362	315	677		13.96299	12.21290
2005	407	387	794		16.30958	13.71200
2006	386	384	770		15.75060	12.94935
2007	459	430	889		18.09472	14.16175
2008	492	425	917		18.56101	14.26485
2009	575	462	1,037		20.88336	15.34012
2010	569	510	1,079		21.63200	15.12175
2011	610	469	1,079		21.53199	14.62146
2012	706	589	1,295		25.72235	17.05821
2013	704	646	1,350		26.70150	16.71056
2014	771	649	1,420		27.97304	16.87157
2015	772	704	1,476		28.96860	16.91477
2016	845	708	1,553		30.38368	17.22267
2017	864	779	1,643		32.07061	17.32490
2018	927	792	1,719		33.50820	17.51734

^a)Calculated by defining the 2000 mid-year Korean population (July 1, 2000) as the standard population. ^b)Statistically significant trend (P< 0.05).

Abbreviations: AAPC, average annual percent change; ASR, age-standardized incidence rate; CIR, crude incidence rate; IRR, incidence rate ratio.

Blood Res 2021;56:301~314 https://doi.org/10.5045/br.2021.2021187